(Q73515400)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Correlation of tissue and blood plasminogen activation system in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

S Y Rha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

W I Yang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S J Gong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J J Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

N C Yoo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J K Roh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J S Min

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K S Lee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

B S Kim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H C Chung

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

150

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

137-145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Plasminogen activator inhibitors: hormonally regulated serpins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Levels of plasminogen activator inhibitor type 1 and urokinase plasminogen activator receptor in non-small cell lung cancer as measured by quantitative ELISA and semiquantitative immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

The urokinase type of plasminogen activator in cancer of digestive tracts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

The urokinase-type plasminogen activator system in cancer metastasis: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Plasminogen activator inhibitor 1 in human carcinoma tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2899%2900376-6

7 January 2021

10.1016/S0304-3835(99)00376-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704735%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference